Login to Your Account



Positive Phase II Results Boost Astex Shares

By Catherine Shaffer
Staff Writer

Thursday, August 29, 2013
Shares of Astex Pharmaceuticals Inc. surged 24 percent Wednesday on top-line results from the company’s Phase II trial of cancer candidate SGI-110 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription